Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 8Lung Neoplasms 5Colorectal Neoplasms 3Prostatic Neoplasms 2Neoplasm Metastasis 2Melanoma 2Hot Flashes 2Glioblastoma 2Carcinoma, Non-Small-Cell Lung 2COVID-19 2Brain Neoplasms 2Water-Electrolyte Imbalance 1Ventilator-Induced Lung Injury 1Surgical Wound 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Severe Acute Respiratory Syndrome 1Rectal Neoplasms 1Postoperative Complications 1Pathologic Complete Response 1Neoplasm, Residual 1Mastocytosis 1Lymphopenia 1Lymphoma, Non-Hodgkin 1Lymphedema 1Lower Urinary Tract Symptoms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Leukemia, Myeloid, Acute 1Leukemia, Hairy Cell 1Hypersensitivity 1

Interventions

mirabegron 1bicalutamide 1Tamoxifen 1Sugars 1Sodium Chloride 1Pentosan Sulfuric Polyester 1Dutasteride 1Doxazosin 1Celecoxib 1Capsules 1Botulinum Toxins, Type A 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lower Urinary Tract Symptoms × Sodium Chloride × Clear all
NCT00681148 2013-11-21

Botulinum Toxin Injection With Prostate Brachytherapy

Emory University

Phase 2 Withdrawn
Genitourinary

Prostatic Neoplasms, Lower Urinary Tract Symptoms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡